Sanzen Pharmaceuticals Private Limited

Sanzen Pharmaceuticals Private Limited - chemicals in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U24100TG2023PTC170463 Incorporated 16 January 2023 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2025
₹87,117
Latest filing
Net loss · FY 2025
₹20,202
Net margin -23.2%
EBITDA · FY 2025
-₹20,202
EBITDA margin -23.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Sanzen Pharmaceuticals Private Limited

Data last updated:

Sanzen Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 16 January 2023.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2023PTC170463.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Subhanishaik Mahaboob and Ranjeet Reddy Gouni.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.62 Sy.No.105 Mogals Colony Mailardevpally Chandrayanagutta, Hyderabad, Telangana, India – 500005.

As per the financials filed for FY 2025, the company reported a revenue of ₹87,117. For the same year it recorded a net loss of ₹20,202 (net margin -23.2%) and EBITDA of -₹20,202 (EBITDA margin -23.2%).

Company details

CIN U24100TG2023PTC170463
Registration Number 170463
Incorporation Date 16 January 2023
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025

Contact details

Sanzen Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.

  • Registered Address
    Plot No.62 Sy.No.105 Mogals Colony Mailardevpally Chandrayanagutta, Hyderabad, Telangana, India – 500005
  • Industry
    Chemicals, Manufacturing, Basic Chemical
Comprehensive company report
Sanzen Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Sanzen Pharmaceuticals is administrative and support service activities. In detail, this covers office administrative, office support and other business support activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
NAdministrative and support service activities82Office administrative, office support and other business support activities

To see the full business activity and turnover split of Sanzen Pharmaceuticals Private Limited, buy the company report.

Financials of Sanzen Pharmaceuticals Private Limited

FY 2025 filings available

Sanzen Pharmaceuticals Private Limited reported revenue of ₹87,117 for FY 2025.

Revenue · FY 2025
₹87,117
Net loss · FY 2025
₹20,202 margin -23.2%
EBITDA · FY 2025
-₹20,202 margin -23.2%

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹20,202
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹20,202
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin-23.2%
Net Profit Margin-23.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sanzen Pharmaceuticals Private Limited, buy the company report.

Board of directors of Sanzen Pharmaceuticals Private Limited

Sanzen Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Subhanishaik MahaboobDirector16 Jan 20233 Years 9 MonthsCurrent
Ranjeet Reddy GouniAdditional Director01 Mar 20251 Years 8 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sanzen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Sanzen Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Sanzen Pharmaceuticals Private Limited has 3 board changes on record since 2023: 2 appointments and 1 cessation. The latest: Mahammad Shareef ceased to be Director on 01 Mar 2025.

AGM
Sanzen Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Sanzen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Mahammad Shareef ceased to be Director.
Appointed
Ranjeet Reddy Gouni was appointed as Additional Director.
Appointed
Subhanishaik Mahaboob was appointed as Director.
Incorporation
16 Jan 2023
Sanzen Pharmaceuticals Private Limited was registered on 16 Jan 2023 with Roc Hyderabad & aged 3 years 9 months as per MCA records.

Frequently asked questions

Sanzen Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 16 January 2023 (3+ years old) and is registered under CIN U24100TG2023PTC170463.

Sanzen Pharmaceuticals has 2 current directors:

The latest financial statements of Sanzen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Sanzen Pharmaceuticals is U24100TG2023PTC170463. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sanzen Pharmaceuticals was incorporated on 16 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.

Mahammad Shareef ceased to be Director on 01 Mar 2025. Ranjeet Reddy Gouni was appointed as Additional Director on 01 Mar 2025. Subhanishaik Mahaboob was appointed as Director on 16 Jan 2023.

The registered office of Sanzen Pharmaceuticals is at Plot No.62 Sy.No.105 Mogals Colony Mailardevpally Chandrayanagutta, Hyderabad, Telangana, India – 500005.

Sanzen Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

Sanzen Pharmaceuticals can be reached at its registered office: Plot No.62 Sy.No.105 Mogals Colony Mailardevpally Chandrayanagutta, Hyderabad, Telangana, India – 500005.

Sanzen Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.